. 2019 May 10;34(1):1030–1040. doi: 10.1080/14756366.2019.1609469
© 2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Figure 1.
Examples of dual EGFR/HER2 inhibitors.